REFERÊNCIAS PLATIRAN
1. U.S. Public Health Service, National Institutes of Health. Recommendations for the Safe Handling of Parenteral Antineoplastic Drugs, 1983, NIH Publication nº 83-2621. Superintendent of Documents, U.S.Government Printing Office, Washington, D.C. 20402.
2. AMA Council Report. Guidelines for handling Parenteral Antineoplastics. JAMA , 23 : 1590-1592, 1985.
3. National Study Commission on Cytotoxic Exposure : Recommendations for Handling Cytotoxic Agents, 1987. Louis P. Jeffrey, Sc.D., Chairman National Study Commission on Cytotoxic Exposure, Massachusetts College of Pharmacy and Allied Health Sciences, 179 Lonwood Avenue, Boston, Massachusetts 02115.
4. Clinical Oncological Society of Australia : Guidelines and Recommendations for Safe Handling of Antineoplasic Agents. Med. J. Australia, 1 : 426-428, 1983.
5. Jones, R.B. et al . Safe Handling of Chemotherapeutic Agents : A Report from the Mount Sinai Medical Center. Ca-A Cancer1 Journal for Clinicians, 33 : 258-263, 1983.
6. American Society of Hospital Pharmacists Technical Assistance Bulletin on Handling Cytotoxic Drugs in Hospitals. Am. J. Hosp. Pharm., 47 : 1033-1049, 1990.
7. OSHA Work-Practice Guidelines for personnel Dealing with Cytotoxic (Antineoplasic) Drugs. Am. J. Hosp. Pharm., 43 : 1193 - 1204, 1986.
Complementos
Usuário